Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Caplin Point Laboratories
BSE:524742 Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Create a narrative
Caplin Point Laboratories
Popular
Undervalued
Overvalued
Caplin Point Laboratories
AN
Analyst Price Target
Consensus Narrative from 3 Analysts
Expansion Into Latin America And US Injectables Will Strengthen Future Prospects
Key Takeaways Expanding into Latin America and the U.S. market aims to drive significant revenue growth through international expansion and front-end presence. Investments in manufacturing and complex product development could enhance production capacity and improve margins through increased efficiencies.
View narrative
₹2.47k
FV
19.6% undervalued
intrinsic discount
14.17%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
524742
Caplin Point Laboratories
Your Fair Value
₹
Current Price
₹1.99k
3.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
35b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹35.4b
Earnings ₹9.7b
Advanced
Set as Fair Value